Literature DB >> 17215288

Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice.

Atsushi Kato1, Katsuhiro Kiyotani, Toru Kubota, Tetsuya Yoshida, Masato Tashiro, Yoshiyuki Nagai.   

Abstract

The Sendai virus (SeV) C protein blocks signal transduction of interferon (IFN), thereby counteracting the antiviral actions of IFN. Using HeLa cell lines expressing truncated or mutated SeV C proteins, we found that the C-terminal half has anti-IFN capacity, and that K(151)A, E(153)A, and R(154)A substitutions in the C protein eliminated this capacity. Here, we further created the mutant virus SeV Cm*, in which K(151)A, E(153)K, and R(157)L substitutions in the C protein were introduced without changing the amino acid sequence of overlapped P, V, and W proteins. SeV Cm* was found to lack anti-IFN capacity, as expected. While the growth rate and final yield of SeV Cm* were inferior to those of the wild-type SeV in IFN-responsive, STAT1-positive 2fTGH cells, SeV Cm* grew equivalently to the wild-type SeV in IFN-nonresponsive, STAT1-deficient U3A cells. SeV Cm* was thus shown to maintain multiplication capacity, except that it lacked anti-IFN capacity. Intranasally inoculated SeV Cm* could propagate in the lungs of STAT1(-/-) mice but was cleared from those of STAT1(+/+) mice without propagation. It was found that the anti-IFN capacity of the SeV C protein was indispensable for pathogenicity in mice. Conversely, the results show that the innate immunity contributed to elimination of SeV in early stages of infection in the absence of anti-IFN capacity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17215288      PMCID: PMC1866026          DOI: 10.1128/JVI.02590-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Sendai virus wild-type and mutant C proteins show a direct correlation between L polymerase binding and inhibition of viral RNA synthesis.

Authors:  C C Grogan; S A Moyer
Journal:  Virology       Date:  2001-09-15       Impact factor: 3.616

2.  Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis.

Authors:  C Huang; K Kiyotani; Y Fujii; N Fukuhara; A Kato; Y Nagai; T Yoshida; T Sakaguchi
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 3.  Accessory genes of the paramyxoviridae, a large family of nonsegmented negative-strand RNA viruses, as a focus of active investigation by reverse genetics.

Authors:  Y Nagai; A Kato
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

4.  Sendai virus C protein physically associates with Stat1.

Authors:  K Takeuchi; T Komatsu; J Yokoo; A Kato; T Shioda; Y Nagai; B Gotoh
Journal:  Genes Cells       Date:  2001-06       Impact factor: 1.891

5.  C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha.

Authors:  T Kubota; N Yokosawa; S Yokota ; N Fujii
Journal:  Biochem Biophys Res Commun       Date:  2001-04-27       Impact factor: 3.575

6.  Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response.

Authors:  D Garcin; J Curran; M Itoh; D Kolakofsky
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation.

Authors:  L Didcock; D F Young; S Goodbourn; R E Randall
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.

Authors:  A Kato; Y Ohnishi; M Kohase; S Saito; M Tashiro; Y Nagai
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

9.  High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons.

Authors:  M Nishio; M Tsurudome; M Ito; M Kawano; H Komada; Y Ito
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

10.  The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2.

Authors:  J P Parisien; J F Lau; J J Rodriguez; B M Sullivan; A Moscona; G D Parks; R A Lamb; C M Horvath
Journal:  Virology       Date:  2001-05-10       Impact factor: 3.616

View more
  29 in total

1.  Virus-driven conditional expression of an interferon antagonist as a tool to circumvent host restriction.

Authors:  Denis Gerlier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

2.  Respiratory Enterovirus (like Parainfluenza Virus) Can Cause Chronic Lung Disease if Protection by Airway Epithelial STAT1 Is Lost.

Authors:  Yong Zhang; Dailing Mao; Shamus P Keeler; Xinyu Wang; Kangyun Wu; Benjamin J Gerovac; Laurie L Shornick; Eugene V Agapov; Michael J Holtzman
Journal:  J Immunol       Date:  2019-02-25       Impact factor: 5.422

3.  Blockade of virus infection by human CD4+ T cells via a cytokine relay network.

Authors:  Ann M Davis; Kristan A Hagan; Loderick A Matthews; Gagan Bajwa; Michelle A Gill; Michael Gale; J David Farrar
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

Review 4.  Paramyxovirus assembly and budding: building particles that transmit infections.

Authors:  Megan S Harrison; Takemasa Sakaguchi; Anthony P Schmitt
Journal:  Int J Biochem Cell Biol       Date:  2010-04-14       Impact factor: 5.085

5.  A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes.

Authors:  Asuka Yoshida; Ryoko Kawabata; Tomoyuki Honda; Kouji Sakai; Yasushi Ami; Takemasa Sakaguchi; Takashi Irie
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

6.  Measles virus circumvents the host interferon response by different actions of the C and V proteins.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Shinji Ohno; Yuta Shirogane; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

7.  Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses.

Authors:  Takashi Irie; Natsuko Nagata; Tomoki Igarashi; Isao Okamoto; Takemasa Sakaguchi
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

8.  Role of interferon regulatory factor 3-mediated apoptosis in the establishment and maintenance of persistent infection by Sendai virus.

Authors:  Saurabh Chattopadhyay; Volker Fensterl; Ying Zhang; Manoj Veleeparambil; Michifumi Yamashita; Ganes C Sen
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

9.  TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA.

Authors:  Hiroyasu Konno; Takuya Yamamoto; Kohsuke Yamazaki; Jin Gohda; Taishin Akiyama; Kentaro Semba; Hideo Goto; Atsushi Kato; Toshiaki Yujiri; Takahiko Imai; Yasushi Kawaguchi; Bing Su; Osamu Takeuchi; Shizuo Akira; Yasuko Tsunetsugu-Yokota; Jun-ichiro Inoue
Journal:  PLoS One       Date:  2009-05-25       Impact factor: 3.240

10.  Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor.

Authors:  Grégory Caignard; Anastassia V Komarova; Mehdi Bouraï; Thomas Mourez; Yves Jacob; Louis M Jones; Flore Rozenberg; Astrid Vabret; François Freymuth; Frédéric Tangy; Pierre-Olivier Vidalain
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.